1. Home
  2. ABVX vs VNOM Comparison

ABVX vs VNOM Comparison

Compare ABVX & VNOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVX
  • VNOM
  • Stock Information
  • Founded
  • ABVX 2013
  • VNOM 2013
  • Country
  • ABVX France
  • VNOM United States
  • Employees
  • ABVX N/A
  • VNOM N/A
  • Industry
  • ABVX
  • VNOM Oil & Gas Production
  • Sector
  • ABVX
  • VNOM Energy
  • Exchange
  • ABVX Nasdaq
  • VNOM Nasdaq
  • Market Cap
  • ABVX 5.3B
  • VNOM 6.3B
  • IPO Year
  • ABVX N/A
  • VNOM 2014
  • Fundamental
  • Price
  • ABVX $84.01
  • VNOM $38.57
  • Analyst Decision
  • ABVX Strong Buy
  • VNOM Strong Buy
  • Analyst Count
  • ABVX 8
  • VNOM 14
  • Target Price
  • ABVX $90.63
  • VNOM $55.15
  • AVG Volume (30 Days)
  • ABVX 1.2M
  • VNOM 2.4M
  • Earning Date
  • ABVX 08-11-2025
  • VNOM 11-03-2025
  • Dividend Yield
  • ABVX N/A
  • VNOM 6.35%
  • EPS Growth
  • ABVX N/A
  • VNOM 16.12
  • EPS
  • ABVX N/A
  • VNOM 3.30
  • Revenue
  • ABVX $7,073,400.00
  • VNOM $932,200,000.00
  • Revenue This Year
  • ABVX $25.23
  • VNOM $71.32
  • Revenue Next Year
  • ABVX N/A
  • VNOM $39.00
  • P/E Ratio
  • ABVX N/A
  • VNOM $11.69
  • Revenue Growth
  • ABVX N/A
  • VNOM 5.03
  • 52 Week Low
  • ABVX $4.77
  • VNOM $34.71
  • 52 Week High
  • ABVX $92.91
  • VNOM $56.76
  • Technical
  • Relative Strength Index (RSI)
  • ABVX 67.94
  • VNOM 50.65
  • Support Level
  • ABVX $82.72
  • VNOM $36.44
  • Resistance Level
  • ABVX $91.30
  • VNOM $40.53
  • Average True Range (ATR)
  • ABVX 3.62
  • VNOM 1.10
  • MACD
  • ABVX -1.13
  • VNOM -0.02
  • Stochastic Oscillator
  • ABVX 47.89
  • VNOM 52.08

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

About VNOM Viper Energy Inc.

Viper Energy Inc is focused on owning and acquiring mineral and royalty interests in oil and natural gas properties in the Permian Basin. The Permian Basin is known to have a number of zones of oil and natural gas-bearing rock throughout.

Share on Social Networks: